Santen Pharmaceutical Co's total assets for Q4 2025 were ¥409.28B, an increase of 2.75% from the previous quarter. SNPHY total liabilities were ¥124.10B for the fiscal quarter, a 7.82% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.